Free CPD Education: AndroFeme 1 Guide for Prescribers + Diagnose & Manage HSDD
Empower Your Practice: Address HSDD with Confidence – Now with Androfeme 1 Insights
Hypoactive Sexual Desire Disorder (HSDD) is a common yet often under-recognised concern in general practice—particularly among postmenopausal women. This CPD-approved education from Praxhub combines two essential modules to support your clinical expertise:
✔️ Diagnose & Manage HSDD
Gain a comprehensive, evidence-based approach to assessing and managing HSDD in the Australian clinical setting.
- Identify biological, psychological, and interpersonal factors
- Use validated screening tools for accurate diagnosis
- Explore diverse management options
✔️ AndroFeme 1: A Guide for Prescribers
Learn practical prescribing guidance for testosterone therapy in women, including safety, dosing, and monitoring.
⏱ 30-minute modules | Earn up to 2.5 CPD hours
Join now to enhance your confidence and make a meaningful impact on your patients’ quality of life.
👉 Register today to upskill in HSDD care and prescribing AndroFeme 1.
Latest News
AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT
MEDIA RELEASE – Wed 11 February 2026 AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT A small Perth-based pharmaceutical company is stepping up… Continue Reading →
PBAC says NO!
The outcome of the November 2025 meeting of the Pharmaceuticals Benefits Advisory Committee (PBAC) has determined that AndroFeme® 1 testosterone cream for the treatment… Continue Reading →